Literature DB >> 17406254

Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions.

Kevin D G Pfleger1, Ruth M Seeber, Karin A Eidne.   

Abstract

A substantial range of protein-protein interactions can be readily monitored in real time using bioluminescence resonance energy transfer (BRET). The procedure involves heterologous coexpression of fusion proteins, which link proteins of interest to a bioluminescent donor enzyme or acceptor fluorophore. Energy transfer between these proteins is then detected. This protocol encompasses BRET1, BRET2 and the recently described eBRET, including selection of the donor, acceptor and substrate combination, fusion construct generation and validation, cell culture, fluorescence and luminescence detection, BRET detection and data analysis. The protocol is particularly suited to studying protein-protein interactions in live cells (adherent or in suspension), but cell extracts and purified proteins can also be used. Furthermore, although the procedure is illustrated with references to mammalian cell culture conditions, this protocol can be readily used for bacterial or plant studies. Once fusion proteins are generated and validated, the procedure typically takes 48-72 h depending on cell culture requirements.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406254     DOI: 10.1038/nprot.2006.52

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  76 in total

Review 1.  Tools used to study how protein complexes are assembled in signaling cascades.

Authors:  Susan Dwane; Patrick A Kiely
Journal:  Bioeng Bugs       Date:  2011-09-01

2.  Role of receptor-attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors.

Authors:  Luis E Gimenez; Seunghyi Kook; Sergey A Vishnivetskiy; M Rafiuddin Ahmed; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

3.  Bisdeoxycoelenterazine derivatives for improvement of bioluminescence resonance energy transfer assays.

Authors:  Jelena Levi; Abhijit De; Zhen Cheng; Sanjiv Sam Gambhir
Journal:  J Am Chem Soc       Date:  2007-09-12       Impact factor: 15.419

4.  Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays.

Authors:  Hideaki Yano; Alessandro Bonifazi; Min Xu; Daryl A Guthrie; Stephanie N Schneck; Ara M Abramyan; Andrew D Fant; W Conrad Hong; Amy H Newman; Lei Shi
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

5.  Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis.

Authors:  Raelene J Pickering; Christos Tikellis; Carlos J Rosado; Despina Tsorotes; Alexandra Dimitropoulos; Monique Smith; Olivier Huet; Ruth M Seeber; Rekhati Abhayawardana; Elizabeth Km Johnstone; Jonathan Golledge; Yutang Wang; Karin A Jandeleit-Dahm; Mark E Cooper; Kevin Dg Pfleger; Merlin C Thomas
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

6.  BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.

Authors:  Karen Lavery; Pamela Swain; Dean Falb; Moulay Hicham Alaoui-Ismaili
Journal:  J Biol Chem       Date:  2008-04-24       Impact factor: 5.157

7.  hnRNP A1 and hnRNP H can collaborate to modulate 5' splice site selection.

Authors:  Jean-François Fisette; Johanne Toutant; Samuel Dugré-Brisson; Luc Desgroseillers; Benoit Chabot
Journal:  RNA       Date:  2009-11-19       Impact factor: 4.942

8.  The constitutively active V2 receptor mutants conferring NSIAD are weakly sensitive to agonist and antagonist regulation.

Authors:  Julie Tenenbaum; Mohammed A Ayoub; Sanja Perkovska; Anne-Laure Adra-Delenne; Christiane Mendre; Bruno Ranchin; Giamperro Bricca; Ghislaine Geelen; Bernard Mouillac; Thierry Durroux; Denis Morin
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

9.  Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis.

Authors:  Martina Kocan; Heng B See; Natália G Sampaio; Karin A Eidne; Brian J Feldman; Kevin D G Pfleger
Journal:  Mol Endocrinol       Date:  2009-01-29

10.  Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling.

Authors:  Ib V Klewe; Søren M Nielsen; Louise Tarpø; Eneko Urizar; Concetta Dipace; Jonathan A Javitch; Ulrik Gether; Jan Egebjerg; Kenneth V Christensen
Journal:  Neuropharmacology       Date:  2008-04-08       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.